600222.SH
Henan Taloph Pharmaceutical Stock Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 6.55
+2.34%Oct 30, 2026, 09:10 UTC
Taloph Pharmaceutical reported revenue of 1.133 billion yuan for the first three quarters of 2026, down 4.57% year over year, and net profit attributable to shareholders of 16.236 million yuan, down 35.89%.
Source:Oct 30, 2026, 09:10 UTC
Taloph Pharmaceutical reported third-quarter 2026 revenue of 395 million yuan, down 7.02% year over year, and net profit attributable to shareholders of 4.2033 million yuan, down 29.70%.
Source:Oct 13, 2026, 10:03 UTC
Talon Pharmaceutical said the National Association of Financial Market Institutional Investors registered its medium-term notes for up to 600 million yuan, with the registration valid for two years from the notice date.
Source:Sep 9, 2026, 09:37 UTC
Zhengzhou Zhongsheng Industrial Group's 50 million shares in Tailong Pharmaceutical were placed under sequential freeze by a court order at the request of Zhongyuan Bank's Zhengzhou Zhongzhou Avenue sub-branch.
Source: